Citigroup
ACHV icon

Citigroup’s Achieve Life Sciences ACHV Stock Holding History

Citigroup’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$484K Buy
74,114
+68,666
+1,260% +$327K ﹤0.01% 3915
2026
Q1 		$16K Sell
5,448
-27,520
-83% -$122K ﹤0.01% 4891
2025
Q4 		$164K Buy
+32,968
New +$144K ﹤0.01% 4085
2025
Q2 		– Sell
-24,252
Closed -$64.8K – 5625
2025
Q1 		$64.8K Sell
24,252
-22,841
-49% -$71K ﹤0.01% 4802
2024
Q4 		$166K Buy
47,093
+22,157
+89% +$100K ﹤0.01% 4527
2024
Q3 		$118K Buy
24,936
+17,349
+229% +$79.3K ﹤0.01% 4692
2024
Q2 		$35.7K Buy
+7,587
New +$36.6K ﹤0.01% 4778
2018
Q3 		– Sell
-1
Closed – – 7721
2018
Q2 		$0 Buy
+1
New +$204 ﹤0.01% 7584
2018
Q1 		– Sell
-4
Closed -$1K – 7516
2017
Q4 		$1K Hold
4
– – ﹤0.01% 7453
2017
Q3 		$2K Hold
4
– – ﹤0.01% 7005
2017
Q2 		$4K Sell
4
-1
-20% -$811 ﹤0.01% 6780
2017
Q1 		$4K Hold
5
– – ﹤0.01% 6842
2016
Q4 		$5K Hold
5
– – ﹤0.01% 6904
2016
Q3 		$5K Hold
5
– – ﹤0.01% 6752
2016
Q2 		$11K Hold
5
– – ﹤0.01% 6480
2016
Q1 		$7K Hold
5
– – ﹤0.01% 6892
2015
Q4 		$13K Hold
5
– – ﹤0.01% 6679
2015
Q3 		$23K Hold
5
– – ﹤0.01% 5928
2015
Q2 		$24K Hold
5
– – ﹤0.01% 5991
2015
Q1 		$22K Hold
5
– – ﹤0.01% 6044
2014
Q4 		$24K Hold
5
– – ﹤0.01% 6119
2014
Q3 		$31K Sell
5
-1
-17% -$6.95K ﹤0.01% 5615
2014
Q2 		$50K Hold
6
– – ﹤0.01% 5167
2014
Q1 		$149K Sell
6
-1
-14% -$24.6K ﹤0.01% 4625
2013
Q4 		$120K Buy
7
+3
+75% +$52.6K ﹤0.01% 5107
2013
Q3 		$91K Hold
4
– – ﹤0.01% 4805
2013
Q2 		$96K Buy
+4
New +$89.5K ﹤0.01% 4889

Other funds holding ACHV

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBM
Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Citigroup's ACHV Position: Q2 2026 in Review

Citigroup increased its Achieve Life Sciences (ACHV) stake by 1,260% in Q2 2026, buying an estimated $327K and bringing the position to 74,114 shares worth $484K. The position accounts for ﹤0.01% of the portfolio, ranked #3915.

Citigroup first reported a position in ACHV in Q2 2013 and has held it in 27 quarters since. 111 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

  • Citigroup held 74,114 shares of Achieve Life Sciences worth $484K as of Q2 2026.
  • Citigroup bought 68,666 Achieve Life Sciences shares in Q2 2026, an estimated $327K.
  • Achieve Life Sciences made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #3915 holding.
  • Citigroup first reported a position in Achieve Life Sciences in Q2 2013 and has held it in 27 quarters since.
  • 111 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.